Chemed Co. (NYSE:CHE) Receives Consensus Rating of “Hold” from Analysts

Chemed Co. (NYSE:CHE) has received a consensus recommendation of “Hold” from the six ratings firms that are covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $466.25.

A number of equities analysts recently weighed in on CHE shares. Oppenheimer boosted their target price on shares of Chemed from $440.00 to $470.00 and gave the stock a “market perform” rating in a report on Monday, November 25th. JMP Securities upgraded shares of Chemed from a “market perform” rating to an “outperform” rating and set a $490.00 target price on the stock in a report on Friday, November 1st. Finally, ValuEngine downgraded shares of Chemed from a “hold” rating to a “sell” rating in a report on Tuesday, December 3rd.

In other Chemed news, VP Naomi C. Dallob sold 660 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $433.50, for a total value of $286,110.00. Following the transaction, the vice president now directly owns 4,671 shares in the company, valued at $2,024,878.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Michael D. Witzeman sold 2,500 shares of the company’s stock in a transaction on Wednesday, December 4th. The shares were sold at an average price of $432.69, for a total transaction of $1,081,725.00. Over the last quarter, insiders sold 6,480 shares of company stock worth $2,919,766. Corporate insiders own 3.96% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the business. Great Diamond Partners LLC acquired a new position in shares of Chemed in the fourth quarter valued at about $36,000. Sowell Financial Services LLC grew its stake in shares of Chemed by 876.9% in the fourth quarter. Sowell Financial Services LLC now owns 127 shares of the company’s stock valued at $56,000 after acquiring an additional 114 shares in the last quarter. Fieldpoint Private Securities LLC grew its stake in shares of Chemed by 76.7% in the fourth quarter. Fieldpoint Private Securities LLC now owns 182 shares of the company’s stock valued at $80,000 after acquiring an additional 79 shares in the last quarter. Exane Derivatives acquired a new position in shares of Chemed in the fourth quarter valued at about $89,000. Finally, Pendal Group Ltd acquired a new position in shares of Chemed in the fourth quarter valued at about $87,000. Hedge funds and other institutional investors own 88.82% of the company’s stock.

CHE traded up $0.05 during trading on Friday, reaching $491.69. 159,829 shares of the stock were exchanged. Chemed has a twelve month low of $310.28 and a twelve month high of $494.76. The stock’s 50 day moving average price is $467.09 and its two-hundred day moving average price is $432.94.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Article: What is a stock portfolio tracker?

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.